LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

DNA-Based Platform Detects Traces of Molecules from Broad Range of Sources

By LabMedica International staff writers
Posted on 19 Jul 2016
Image: New research uses DNA technology to detect a wide range of substances (Photo courtesy of ScienceBlog).
Image: New research uses DNA technology to detect a wide range of substances (Photo courtesy of ScienceBlog).
Researchers have harnessed synthetic DNA technology to develop a super-efficient nanomachine that detects trace amounts of substances that range from viruses and bacteria to cocaine and metals.

"It's a completely new platform that can be adapted to many kinds of uses," said co-author John Brennan, director of Biointerfaces Insitute, McMaster University (Hamilton, Ontario, Canada), "These DNA nano-architectures are adaptable, so that any target should be detectable." Besides being life’s genetic material, DNA is also a very programmable molecule that lends itself to engineering for synthetic applications. The new method shapes separately programmed pieces of DNA material into pairs of interlocking circles. The first remains inactive until it is released by the second, like a bicycle wheel in a lock. When the second circle, acting as the lock, is exposed to even a trace of the target substance, it opens, freeing the first circle of DNA, which replicates quickly and creates a signal, such as a color change.

"The key is that it's selectively triggered by whatever we want to detect," said Prof. Brennan, "We have essentially taken a piece of DNA and forced it to do something it was never designed to do. We can design the lock to be specific to a certain key. All the parts are made of DNA, and ultimately that key is defined by how we build it."

The idea came from nature itself, explained co-author Yingfu Li, who holds the Canada Research Chair in Nucleic Acids Research, "Biology uses all kinds of nanoscale molecular machines to achieve important functions in cells," said Prof. Li, "For the first time, we have designed a DNA-based nanomachine that is capable of achieving ultra-sensitive detection of a bacterial pathogen." The DNA-based nanomachine is being further developed into a user-friendly detection kit that will enable rapid testing of a variety of substances, and could move to clinical testing within a year.

The study, by Liu M et al, was published June 23, 2016, in the journal Nature Communications.

Related Links:
McMaster University


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Capillary Blood Collection Tube
IMPROMINI M3

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more